American Financial Statements From 2010 to 2024

AMMJ Stock  USD 0.0002  0.0003  60.00%   
American Cannabis financial statements provide useful quarterly and yearly information to potential American Cannabis investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on American Cannabis financial statements helps investors assess American Cannabis' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting American Cannabis' valuation are summarized below:
American Cannabis does not presently have any fundamental signals for analysis.
Check American Cannabis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among American Cannabis' main balance sheet or income statement drivers, such as , as well as many indicators such as . American financial statements analysis is a perfect complement when working with American Cannabis Valuation or Volatility modules.
  
This module can also supplement various American Cannabis Technical models . Check out the analysis of American Cannabis Correlation against competitors.

American Cannabis Company Current Valuation Analysis

American Cannabis' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current American Cannabis Current Valuation

    
  3.49 M  
Most of American Cannabis' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, American Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, American Cannabis has a Current Valuation of 3.49 M. This is 99.95% lower than that of the Industrials sector and significantly higher than that of the Consulting Services industry. The current valuation for all United States stocks is 99.98% higher than that of the company.

American Cannabis Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining American Cannabis's current stock value. Our valuation model uses many indicators to compare American Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across American Cannabis competition to find correlations between indicators driving American Cannabis's intrinsic value. More Info.
American Cannabis is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the American Cannabis' earnings, one of the primary drivers of an investment's value.

About American Cannabis Financial Statements

Investors use fundamental indicators, such as American Cannabis' revenue or net income, to determine how well the company is positioned to perform in the future. Although American Cannabis' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
American Cannabis Company, Inc., together with its subsidiary, Hollister Blacksmith, Inc., provides solutions for businesses operating in the regulated cannabis industry in the United States and Canada. American Cannabis Company, Inc. was founded in 2013 and is headquartered in Denver, Colorado. American Cannabis operates under Consulting Services classification in the United States and is traded on OTC Exchange. It employs 7 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in American Pink Sheet

American Cannabis financial ratios help investors to determine whether American Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in American with respect to the benefits of owning American Cannabis security.